Yizhao Research
Log in
▣ Pharma & biotech◆ Chemical pharma📅 2026/10/2Extreme data ★3

920547 No Chemical pharma, Crystal Sea Fundamental Research and Analysis Report.

(920547) The current price of Chemical pharma Crystal Sea is 19.36 yuan, the medium and long-term price trend (weekly K-line MA10) is more, the current structure of weekly K-line is volatile, the recent price trend (daily K-line MA10) is more, and the current form of daily K-line is rising. The medium- to long-term price trend of the Shanghai Composite Index (weekly MA10) is bullish. Strong operations, mid-range valuation. Core indicators deducted non-ROE current 5.07, 107.48 YoY. Core metrics Operating cash flow/net profit 0.60 for the period, up -19.06 YoY. Core indicator price-to-earnings ratio PE current 22.46, up -45.92 YoY, 4.54 month-on-month. The core indicator price-to-book ratio PB was 2.04 in the current period, up -35.14 YoY and 4.54 YoY. Key indicator: Manufacturing PMI new orders stood at 50.60 this period, placing it at the 50th percentile over the past 10 years, up 2.22% year-on-year and 4.33% month-on-month.

Full reportLog in to download

Full report and figures: download the original Chinese file.


(920547) The current price of Chemical pharma Crystal Sea is 19.36 yuan, the medium and long-term price trend (weekly K-line MA10) is more, the current structure of weekly K-line is volatile, the recent price trend (daily K-line MA10) is more, and the current form of daily K-line is rising. The medium- to long-term price trend of the Shanghai Composite Index (weekly MA10) is bullish. Strong operations, mid-range valuation. Core indicators deducted non-ROE current 5.07, 107.48 YoY. Core metrics Operating cash flow/net profit 0.60 for the period, up -19.06 YoY. Core indicator price-to-earnings ratio PE current 22.46, up -45.92 YoY, 4.54 month-on-month. The core indicator price-to-book ratio PB was 2.04 in the current period, up -35.14 YoY and 4.54 YoY. Key indicator: Manufacturing PMI new orders stood at 50.60 this period, placing it at the 50th percentile over the past 10 years, up 2.22% year-on-year and 4.33% month-on-month.